A detailed history of Pax Financial Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Pax Financial Group, LLC holds 13,099 shares of INCY stock, worth $1.01 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
13,099
Previous 13,807 5.13%
Holding current value
$1.01 Million
Previous $836,000 3.47%
% of portfolio
0.16%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $40,589 - $48,575
-708 Reduced 5.13%
13,099 $865,000
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $29,735 - $37,038
-581 Reduced 4.04%
13,807 $836,000
Q1 2024

May 13, 2024

SELL
$56.55 - $66.59 $20,018 - $23,572
-354 Reduced 2.4%
14,388 $819,000
Q4 2023

Feb 12, 2024

SELL
$52.16 - $64.19 $16,221 - $19,963
-311 Reduced 2.07%
14,742 $925,000
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $26,458 - $30,195
458 Added 3.14%
15,053 $869,000
Q2 2023

Jul 18, 2023

BUY
$60.95 - $75.51 $30,048 - $37,226
493 Added 3.5%
14,595 $908,000
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $25,212 - $30,877
359 Added 2.61%
14,102 $1.02 Million
Q4 2022

Feb 10, 2023

SELL
$67.18 - $84.11 $117,229 - $146,771
-1,745 Reduced 11.27%
13,743 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $38,053 - $47,644
575 Added 3.86%
15,488 $1.03 Million
Q2 2022

Aug 09, 2022

SELL
$66.18 - $83.18 $98,674 - $124,021
-1,491 Reduced 9.09%
14,913 $1.13 Million
Q1 2022

May 10, 2022

BUY
$66.02 - $79.71 $111,177 - $134,231
1,684 Added 11.44%
16,404 $1.3 Million
Q4 2021

Feb 07, 2022

BUY
$63.34 - $74.11 $283,573 - $331,790
4,477 Added 43.71%
14,720 $1.08 Million
Q3 2021

Oct 29, 2021

BUY
$68.67 - $84.02 $202,782 - $248,111
2,953 Added 40.51%
10,243 $705,000
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $203,349 - $222,851
2,546 Added 53.67%
7,290 $613,000
Q1 2021

May 10, 2021

BUY
$76.02 - $100.5 $360,638 - $476,772
4,744 New
4,744 $386,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Pax Financial Group, LLC Portfolio

Follow Pax Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.